Well, here we sit in 2026. We haven't found a cure. We've done a lot with the new B cell therapies, Ocrevus, Rituxan, all of that that, you know, and We can really tamp down, relapsing, remitting MS, but we haven't made much progress on repairing damage. that's already been done for those people who are living with Ms. And have had been impacted, like all of us. So that's the sad, frustrating thing. (19:48–20:00)
CLAIM
Asserts that while relapsing-remitting MS can be managed, progress on repairing MS damage is limited.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
